PROM1 and colorectal cancer: Although CD133 silencing does not alter the apoptosis of colorectal cancer cells [20, 21], the combined CD133 silencing with oxaliplatin potentiates the oxaliplatin-mediated apoptosis in colorectal cancer cells [21].